EXPONENT, INC. vs GENPACT LIMITED, two Consulting stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where EXPO and G diverge most: on debt / equity, EXPO reads 0.00 and G reads 0.77; on p/s, EXPO reads 5.56 and G reads 1.18. The rest of the comparable metrics sit closer together. What EXPO's price implies is a bet that sits within the historical range (whole-company basis). What G's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | EXPO | G |
|---|---|---|
| Price | $66.86 | $35.19 |
| Market cap | $3.4B | $6.1B |
| Sector | Consulting | Consulting |
| Stage | Mature | Mature |
| Implied growth (priced in) | +24.5% | — |
| P/E | 31.2 | 10.8 |
| P/B | 9.90 | 2.46 |
| P/S | 5.56 | 1.18 |
| EV/EBITDA | 25.5 | 9.5 |
| Revenue growth | +7.8% | +6.4% |
| Gross margin | — | 36.4% |
| Operating margin | 24.9% | 15.3% |
| Net margin | 18.1% | 11.0% |
| Return on equity | 32.2% | 23.0% |
| Return on assets | 15.8% | 10.1% |
| Return on invested capital | 24.1% | 13.3% |
| FCF yield | 3.4% | 11.0% |
| Dividend yield | 1.8% | 1.9% |
| Debt / equity | 0.00 | 0.77 |
| Current ratio | 2.40 | 1.69 |
| Altman Z (solvency) | 8.57 | 2.76 |
| Piotroski F (quality) | 6 / 9 | 3 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.